Provided by Tiger Fintech (Singapore) Pte. Ltd.

Valneva SE

6.57
-0.4850-6.88%
Volume:11.04K
Turnover:75.85K
Market Cap:533.07M
PE:-37.72
High:7.01
Open:7.01
Low:6.54
Close:7.05
Loading ...

Valneva Reports Positive Three-Year Antibody Persistence Data for its Single-Shot Chikungunya Vaccine IXCHIQ®

GlobeNewswire
·
03 Dec 2024

Chikungunya Vaccine Label Extension Call Likely to Support VALN Stock

Zacks
·
28 Nov 2024

Valneva Seeks FDA Approval for Expanded Vaccine Use

TIPRANKS
·
27 Nov 2024

Valneva Submits Label Extension Application to US FDA for Chikungunya Vaccine IXCHIQ

MT Newswires Live
·
27 Nov 2024

Valneva submits label extension application for chikungunya vaccine to FDA

TIPRANKS
·
27 Nov 2024

Valneva Submits Label Extension Application for its Chikungunya Vaccine, IXCHIQ®, to the U.S. FDA

GlobeNewswire
·
27 Nov 2024

High Growth Tech Stocks To Explore This November 2024

Simply Wall St.
·
25 Nov 2024

RFK Jr.'s Nomination to Head Health Department Will Shake Up Vaccine Landscape -- Market Talk

Dow Jones
·
15 Nov 2024

Vaccine Sector Sell-Off Looks Overdone -- Market Talk

Dow Jones
·
15 Nov 2024

European Vaccine Makers Under Pressure After Trump Picks RFK Jr to Lead Health Department

Dow Jones
·
15 Nov 2024

Valneva Engages Investors with Promising Vaccine Developments

TIPRANKS
·
14 Nov 2024

Valneva and LimmaTech Announce First Vaccination in Phase 2b Human Challenge Study of Tetravalent Shigella Vaccine Candidate S4V2

GlobeNewswire
·
14 Nov 2024

Valneva to Present and Hold Investor Meetings at Upcoming U.S. and European Healthcare Conferences

GlobeNewswire
·
12 Nov 2024

Valneva SE (INRLF) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Improved ...

GuruFocus.com
·
08 Nov 2024

Valneva Narrows Its 2024 Guidance: Now Expects Total Revenues Of €170M-€180M (Prior €170M-€190M), And R&D Investments Between €65M-€75M

Benzinga
·
07 Nov 2024

Valneva's Revenue For Nine Months €116.637M Up From €111.8M YoY; EPS €0.17 Up From €(0.50) YoY; Cash Position Of €156.335M

Benzinga
·
07 Nov 2024

Valneva Reports Nine-Month 2024 Financial Results and Provides Corporate Updates

GlobeNewswire
·
07 Nov 2024

VALNEVA - Declaration of shares and voting rights: October 31, 2024

GlobeNewswire
·
06 Nov 2024

Valneva SE expected to post a loss of 26 cents a share - Earnings Preview

Reuters
·
05 Nov 2024

Lectra And 2 Other High Growth Tech Stocks In France

Simply Wall St.
·
24 Oct 2024